🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Approximately 30% of patients with rheumatoid arthritis have an inadequate ...
Status
Completed
Location
Polyclinique de Picardie
Start Date
2009-12-23
Trial ID
NCT01000441
Treatments Being Tested
The inclusion criteria for this study were patients aged 18 to 75 years wit...
Status
Recruiting
Location
Taichung Veterans Hospital
Start Date
2025-07-29
Trial ID
NCT07149792
Treatments Being Tested
This study evaluates the safety profile and effectiveness of adalimumab in ...
Status
Completed
Location
Kyungpook National Univ Hosp /ID# 147937
Start Date
2016-02-18
Trial ID
NCT02687828
To investigate efficacy, safety and pharmacokinetics of adalimumab subcutan...
Status
Completed
Location
Site Reference ID/Investigator# 46738
Start Date
2010-10
Trial ID
NCT01243671
Treatments Being Tested
Dupuytren's disease is a very common condition, affecting 4% of the general...
Status
Completed
Location
The University Medical Centre
Start Date
2016-03-02
Trial ID
NCT03180957
Treatments Being Tested
This is a Phase II, randomized, active-controlled, double-blind, double-dum...
Status
Terminated
Location
Rheumatology Associates
Start Date
2009-03-05
Trial ID
NCT00808210
Treatments Being Tested
This observational study will document to what extent in daily clinical pra...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-05
Trial ID
NCT01845818
To compare PK, safety and tolerability of LBAL developed by LG Life Science...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02206867
Multicenter Early Access Program of the Safety of Human Anti-TNF Monoclonal...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00650026
Treatments Being Tested
This study is conducted to evaluate the short (12 Weeks) and long term (104...
Status
Completed
Location
141
Start Date
2011-12
Trial ID
NCT01500278
Treatments Being Tested